Journal
JOURNAL OF NEUROSCIENCE
Volume 28, Issue 9, Pages 1997-2005Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.4231-07.2008
Keywords
dynactin; p150(Glued); ALS; motor neuron disease model; vesicular trafficking; autophagy
Categories
Funding
- NINDS NIH HHS [R01 NS040014, R01 NS40014] Funding Source: Medline
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS), a fatal and progressive neurodegenerative disorder characterized by weakness, muscle atrophy, and spasticity, is the most common adult-onset motor neuron disease. Although the majority of ALS cases are sporadic, similar to 5-10% are familial, including those linked to mutations in S0D1 (Cu/Zn superoxide dismutase). Missense mutations in a dynactin gene (DCTN1) encoding the p150(Glued) subunit of dynactin have been linked to both familial and sporadic ALS. To determine the molecular mechanism whereby mutant dynactin p150Glued causes selective degeneration of motor neurons, we generated and characterized mice expressing either wild-type or mutant human dynactin p150Glued. Neuronal expression of mutant, but not wild type, dynactin p150Glued causes motor neuron disease in these animals that are characterized by defects in vesicular transport in cell bodies of motor neurons, axonal swelling and axo-terminal degeneration. Importantly, we provide evidence that autophagic cell death is implicated in the pathogenesis of mutant p150Glued mice. This novel mouse model will be instrumental for not only clarifying disease mechanisms in ALS, but also for testing therapeutic strategies to ameliorate this devastating disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available